Livagen
Also known as: Lys-Glu-Asp-Ala
Livagen is a synthetic tetrapeptide (Lys-Glu-Asp-Ala / KEDA) from the Khavinson short-peptide 'bioregulator' series, developed at the St. Petersburg Institute of Bioregulation and Gerontology. Marketed in Russia primarily as a food-supplement-grade cytomax; not FDA-approved in the US; research-use only.
0 listings, ranked by trust score
Each row is a (vendor, peptide) pair. Click through for the listing detail, the vendor's full trust profile, and any COAs they've published.
No vendors carrying this peptide are indexed yet.
COAs for Livagen
8 third-party tests across 2 vendors. Each card links to the full report.
For
Livagen
by BioLongevity Labs· batch cmojb6vlk016ikirxn7h5c3ad
For
Livagen
by Skye Peptides· batch LIV26-25-001
For
Livagen
by BioLongevity Labs· batch 38-3-46035
For
Livagen
by BioLongevity Labs· batch cmojb7apu01a3kirxg8tcvox6
Purity not on file
For
Livagen
by Skye Peptides· batch LIV26-25-001
Purity not on file
For
Livagen
by Skye Peptides· batch LIV26-25-001
Purity not on file
For
Livagen
by BioLongevity Labs· batch 38-3-45958
Purity not on file
For
Livagen
by BioLongevity Labs· batch cmojb7ama01a2kirxmdup77g1